NO983439L - 1-(pyrazol-3-yl-etyl)-4-(indol-3-yl)-piperidin anvendt som medisin som virker på sentralnervesystemet - Google Patents

1-(pyrazol-3-yl-etyl)-4-(indol-3-yl)-piperidin anvendt som medisin som virker på sentralnervesystemet

Info

Publication number
NO983439L
NO983439L NO983439A NO983439A NO983439L NO 983439 L NO983439 L NO 983439L NO 983439 A NO983439 A NO 983439A NO 983439 A NO983439 A NO 983439A NO 983439 L NO983439 L NO 983439L
Authority
NO
Norway
Prior art keywords
indol
pyrazol
medicine
ethyl
acts
Prior art date
Application number
NO983439A
Other languages
English (en)
Norwegian (no)
Other versions
NO983439D0 (no
Inventor
Henning Boettcher
Joachim Maerz
Gerd Bartoszyk
Hartmut Greiner
Juergen Harting
Christoph Seyfried
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO983439D0 publication Critical patent/NO983439D0/no
Publication of NO983439L publication Critical patent/NO983439L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO983439A 1996-01-25 1998-07-24 1-(pyrazol-3-yl-etyl)-4-(indol-3-yl)-piperidin anvendt som medisin som virker på sentralnervesystemet NO983439L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19602505A DE19602505A1 (de) 1996-01-25 1996-01-25 1-(Pyrazol-4-Indol-3-yl)-Piperidine
PCT/EP1997/000187 WO1997027186A1 (de) 1996-01-25 1997-01-17 1-(pyrazol-3-yl-ethyl)-4-(indol-3-yl)-piperidine als das zentralnervensystem beeinflussende mittel

Publications (2)

Publication Number Publication Date
NO983439D0 NO983439D0 (no) 1998-07-24
NO983439L true NO983439L (no) 1998-09-25

Family

ID=7783568

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983439A NO983439L (no) 1996-01-25 1998-07-24 1-(pyrazol-3-yl-etyl)-4-(indol-3-yl)-piperidin anvendt som medisin som virker på sentralnervesystemet

Country Status (16)

Country Link
EP (1) EP0879234A1 (hu)
JP (1) JP2000503972A (hu)
KR (1) KR19990081970A (hu)
CN (1) CN1209807A (hu)
AR (1) AR005549A1 (hu)
AU (1) AU715785B2 (hu)
BR (1) BR9707467A (hu)
CA (1) CA2244136A1 (hu)
CZ (1) CZ231898A3 (hu)
DE (1) DE19602505A1 (hu)
HU (1) HUP9900980A2 (hu)
NO (1) NO983439L (hu)
PL (1) PL328228A1 (hu)
SK (1) SK99298A3 (hu)
WO (1) WO1997027186A1 (hu)
ZA (1) ZA97572B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1214312E (pt) * 1999-09-09 2004-08-31 Lundbeck & Co As H Indoles 5-aminoalquilo e 5-aminocarbonilo substituidos
HUP0203165A3 (en) 1999-11-10 2004-03-29 Takeda Pharmaceutical 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
JP5140225B2 (ja) 2000-08-14 2013-02-06 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド 置換ピラゾール
KR20050036882A (ko) * 2001-11-14 2005-04-20 메르크 파텐트 게엠베하 향정신제로서의 피라졸 유도체
CA2625611A1 (en) 2005-10-11 2007-04-19 F. Hoffman-La Roche Ag Imidazo benzodiazepine derivatives
JP2009515833A (ja) * 2005-10-24 2009-04-16 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 3−ピペリジン−4−イル−インドールorl−1受容体モジュレーター
TWI548630B (zh) * 2011-04-06 2016-09-11 Lg生命科學有限公司 1-(3-氰基-1-異丙基-吲哚-5-基)吡唑-4-羧酸結晶型及其製造方法
TW202225158A (zh) * 2020-11-04 2022-07-01 南韓商Lg化學股份有限公司 1-(3-氰基-1-異丙基-吲哚-5-基)吡唑-4-羧酸結晶之製備方法及包含彼之醫藥組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2060816C3 (de) * 1970-12-10 1980-09-04 Merck Patent Gmbh, 6100 Darmstadt 4-Phenylpiperidinderivate Verfahren zu ihrer Herstellung und pharmazeutische Zubereitungen enthaltend diese Verbindungen
DE2258033A1 (de) * 1972-11-27 1974-05-30 Merck Patent Gmbh Verfahren zur herstellung von pyrazolderivaten
GB8719167D0 (en) * 1987-08-13 1987-09-23 Glaxo Group Ltd Chemical compounds
US5045550A (en) * 1990-09-20 1991-09-03 Warner-Lambert Co. Substituted tetrahydropyridines as central nervous system agents
US5521196A (en) * 1994-10-05 1996-05-28 Eli Lilly And Company 5-HT1F agonists for the treatment of migraine

Also Published As

Publication number Publication date
KR19990081970A (ko) 1999-11-15
SK99298A3 (en) 1999-01-11
NO983439D0 (no) 1998-07-24
ZA97572B (en) 1997-08-04
CZ231898A3 (cs) 1998-10-14
EP0879234A1 (de) 1998-11-25
AU715785B2 (en) 2000-02-10
BR9707467A (pt) 1999-07-20
DE19602505A1 (de) 1997-07-31
AU1443297A (en) 1997-08-20
AR005549A1 (es) 1999-06-23
WO1997027186A1 (de) 1997-07-31
CN1209807A (zh) 1999-03-03
HUP9900980A2 (hu) 1999-07-28
JP2000503972A (ja) 2000-04-04
CA2244136A1 (en) 1997-07-31
PL328228A1 (en) 1999-01-18

Similar Documents

Publication Publication Date Title
ECSP055644A (es) Derivados de la quinolil-propil-piperidina y su utilización
ID21775A (id) Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya
TNSN05069A1 (fr) Derives de la quinolyl propyl piperidine et leur utilisation en tant qu'agents antimicrobiens
CY1109912T1 (el) 3-[(2z)-[1-(3,4-διμεθυλοφαινυλο)-1,5-διυδρο-3-μεθυλο-5-οξο-4η-πυραζολο-4-υλιδενο]υδραζινο-2’-υδροξυ-[1,1’-διφαινυλο]-3-καρβοξυλικο οξυ δι-(μονοαιθανολαμινικο)
GR3033505T3 (en) Indole, indazole and benzisoxazole derivatives as 5-HT1-like agonists.
DE69426331T2 (de) Arzneimittel gegen nervöse erkrankungen
NO971471L (no) Nye karboksamider med fungicid aktivitet
NO993706D0 (no) Pyrrolidinderivater med fosfolipase A2 inhiberende aktivitet
NO308248B1 (no) Forbindelser som er anvendbare som antiproliferative midler og GARFT-inhibitorer, samt farmasøytisk preparat
DE69418789D1 (de) 2-(Piperidin-4-yl, Pyridin-4-yl und Tetrahydropyridin-4-yl)-benzofuran-7-carbamat Derivate, ihre Herstellung und Verwendung als Acetylcholinesterase Inhibitoren
FR2768146B1 (fr) Nouveaux composes de la famille des indole-carboxyliques et leur utilisation
NO983439L (no) 1-(pyrazol-3-yl-etyl)-4-(indol-3-yl)-piperidin anvendt som medisin som virker på sentralnervesystemet
NO985335L (no) 2,4-Diaminopyrimidinderivater
FR2665441B1 (fr) Derives de la n-sulfonyl indoline, leur preparation, les compositions pharmaceutiques en contenant.
CY1108837T1 (el) ΝΕΑ ΠΑΡΑΓΩΓΑ ΑΜΙΝΟΠΥΡΙΔΙΝΗΣ ΩΣ ΑΝΤΑΓΩΝΙΣΤΕΣ mGluR5
DK0785789T3 (da) Diazepinindoler som phosphodiesterase IV-inhibitorer
DK0601486T3 (da) Cis-epoxidderivater, der er egnede som irreversible HIV-proteaseinhibitorer, og fremgangsmåde og mellemprodukter til deres
DK0806413T3 (da) 2-substituerede viatmin D3-derivater
ATE238297T1 (de) Chinolinderivat
DK0541263T3 (da) 5-Piperazinylalkyl-1,5-benzothiazepinoner, der er nyttige som calciumantagonister
DK0791592T3 (da) Azetidiner
DK0613897T3 (da) Piperidinderivater med anti-histamin-og anti-leukotrienaktivitet
DK1219599T3 (da) Vitamin-D-derivater som har substituenter i 2-alfa-position
ATE404548T1 (de) Cyclisches hemiacetalderivat und dessen anwendung
NO974759L (no) Cefalosporinpyridiniumderivater